LIXTE BIOTECHNOLOGY HOLDINGS, INC. - LIXT

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$2.96M
QoQ value delta ($000)
+$761K (+34.61%)
Implied price effect (QoQ)
-21.82%
Shares
Total shares
755,383
QoQ shares delta
+316,642 (+72.17%)
Total shares held by funds (by quarter)

Market chart (LIXT)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q2 2026 data: only 18 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
SCOTIA CAPITAL INC. 1,016 258,713 0.0%
RENAISSANCE TECHNOLOGIES LLC 422 107,500 0.0%
Federation des caisses Desjardins du Quebec 366 93,380 0.0%
VANGUARD GROUP INC 294 74,944 0.0%
DRW Securities, LLC 212 54,126 0.01%
GEODE CAPITAL MANAGEMENT, LLC 204 52,163 0.0%
Ethos Financial Group, LLC 97 24,808 0.01%
STATE STREET CORP 68 17,396 0.0%
TWO SIGMA INVESTMENTS, LP 59 15,174 0.0%
XTX Topco Ltd 57 14,545 0.0%
CITADEL ADVISORS LLC 55 14,093 0.0%
AXXCESS WEALTH MANAGEMENT, LLC 54 13,771 0.0%
Atlas Legacy Advisors, LLC 54 13,771 0.01%
UBS Group AG 2 756 0.0%
BANK OF AMERICA CORP /DE/ 0 52 0.0%
CITIGROUP INC 0 1 0.0%
SBI Securities Co., Ltd. 0 190 0.0%